Inscripta Finds $55.5M For Gene Editing Tools
Boulder, Colorado- annd Pleasanton, California-based Inscripta has received $55.5M in a Series C funding, the company said this week, led by Merieux Developpement and Paladin Capital Group, and also included Venrock, Foresite, Spruce, and NanoDimension. Inscripta, which develops gene editing tools, said the new funding comes in preparation for expansion of its platform, and commercial launch. Kevin Ness is CEO of Inscripta.
posted on Thursday, March 1, 2018 (Link to more information)
Related companies:
Inscripta
Related stories:
> Inscripta Adds $20M To Series C Funding
> Muse bio Finds $23M For Gene Editing Technology
> NewsGator Upgrades Weblog Editing Tool
> Pixorial Upgrades Video Editing, Sharing Service
> Pixorial Integrates With New Google Drive
Techrockies.com Home